Oncopeptides AB (ONPPF)
0.3939
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
Oncopeptides Price to Book Value: 2.915 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 2.915 |
| April 25, 2024 | 2.915 |
| April 24, 2024 | 2.915 |
| April 23, 2024 | 2.915 |
| April 22, 2024 | 2.915 |
| April 19, 2024 | 2.915 |
| April 18, 2024 | 2.915 |
| April 17, 2024 | 2.915 |
| April 16, 2024 | 2.915 |
| April 15, 2024 | 4.440 |
| April 12, 2024 | 4.440 |
| April 11, 2024 | 4.440 |
| April 10, 2024 | 4.440 |
| April 09, 2024 | 4.440 |
| April 08, 2024 | 4.440 |
| April 05, 2024 | 4.440 |
| April 04, 2024 | 4.440 |
| April 03, 2024 | 4.440 |
| April 02, 2024 | 4.440 |
| April 01, 2024 | 4.440 |
| March 28, 2024 | 4.440 |
| March 27, 2024 | 4.440 |
| March 26, 2024 | 4.440 |
| March 25, 2024 | 4.440 |
| March 22, 2024 | 4.440 |
| Date | Value |
|---|---|
| March 21, 2024 | 4.440 |
| March 20, 2024 | 4.440 |
| March 19, 2024 | 4.440 |
| March 18, 2024 | 4.440 |
| March 15, 2024 | 4.440 |
| March 14, 2024 | 4.440 |
| March 13, 2024 | 4.440 |
| March 12, 2024 | 4.440 |
| March 11, 2024 | 4.440 |
| March 08, 2024 | 4.440 |
| March 07, 2024 | 4.440 |
| March 06, 2024 | 4.440 |
| March 05, 2024 | 4.440 |
| March 04, 2024 | 4.440 |
| March 01, 2024 | 4.440 |
| February 29, 2024 | 4.440 |
| February 28, 2024 | 4.440 |
| February 27, 2024 | 4.440 |
| February 26, 2024 | 4.440 |
| February 23, 2024 | 4.440 |
| February 22, 2024 | 4.440 |
| February 21, 2024 | 4.440 |
| February 20, 2024 | 4.440 |
| February 16, 2024 | 4.440 |
| February 15, 2024 | 4.440 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.066
Minimum
Nov 18 2021
21.00
Maximum
Jun 29 2021
4.288
Average
4.440
Median
Nov 02 2023
Price to Book Value Benchmarks
| Abliva AB | 1.504 |
| Karolinska Development AB | 0.5612 |
| Calliditas Therapeutics AB | 15.74 |
| Olink Holding AB | 5.650 |
| BioInvent International AB | 2.673 |
Price to Book Value Related Metrics
| PS Ratio | 12.31 |
| Price | 0.3939 |
| Earnings Yield | -68.82% |
| Market Cap | 35.62M |